Shire PLC Receives Consensus Rating of “Buy” from Brokerages (NASDAQ:SHPGY)
Shire PLC (NASDAQ:SHPGY) has earned an average recommendation of “Buy” from the nine analysts that are presently covering the stock, American Banking News reports. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $260.00.
A number of analysts have recently weighed in on SHPGY shares. Analysts at Shore Capital reiterated a “buy” rating on shares of Shire PLC in a research note on Wednesday. Separately, analysts at Cowen and Company reiterated an “outperform” rating on shares of Shire PLC in a research note on Wednesday. Finally, analysts at Barclays reiterated an “overweight” rating on shares of Shire PLC in a research note on Wednesday.
Shire plc (NASDAQ:SHPGY) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.